Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fragile nucleosomes are essential for RNA Polymerase II to transcribe in eukaryotes.

bioRxiv : the preprint server for biology·2025
Same author

Linear and conformational epitopes of vicilin-buried peptides as a model for improved nut allergy diagnostics.

Frontiers in allergy·2025
Same author

Total IgE as a biomarker of response to omalizumab in chronic urticaria: A prospective study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same author

CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines.

PloS one·2025
Same author

Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding.

The Journal of allergy and clinical immunology·2025
Same author

Skin testing improves predictive value of midrange peanut-specific IgE and Ara h 2 levels in the LEAP study.

The journal of allergy and clinical immunology. In practice·2025
Same journal

Emapalumab plus conventional therapy with or without ruxolitinib for pediatric hemophagocytic lymphohistiocytosis: a single center retrospective study.

Immunologic research·2026
Same journal

Immunological spectrum in patients with thymoma: beyond good syndrome.

Immunologic research·2026
Same journal

Microbiome immune crosstalk in Sjögren's syndrome: mechanistic insights and translational perspectives.

Immunologic research·2026
Same journal

Immune checkpoint inhibitor-induced myasthenia gravis and myocarditis: a fatal immune-related adverse event.

Immunologic research·2026
Same journal

TRIM28 and TRIM32: multifaceted regulators of innate immunity and antiviral defence.

Immunologic research·2026
Same journal

Decoding PANoptosis: Crosstalk of cell death pathways in immunity and inflammation.

Immunologic research·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Redefining the major peanut allergens.

Yonghua Zhuang1, Stephen C Dreskin

  • 1Division of Allergy and Clinical Immunology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA.

Immunologic Research
|September 6, 2012
PubMed
Summary
This summary is machine-generated.

Peanut allergens Ara h 2 and Ara h 6 are the most potent, driving allergic reactions and anaphylaxis. Their allergic effector activity, not just IgE binding, defines major peanut allergens.

More Related Videos

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
09:09

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Related Experiment Videos

Last Updated: May 18, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
09:09

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Area of Science:

  • Immunology
  • Food Science
  • Allergology

Background:

  • Food allergy is a significant public health issue, particularly peanut allergy.
  • Allergens are antigens triggering IgE responses; peanut allergens include multiple proteins.
  • Current definitions of major allergens focus on IgE binding, which may not reflect true allergic potency.

Purpose of the Study:

  • To identify the most active peanut allergens.
  • To evaluate the correlation between IgE binding and allergic effector activity.
  • To propose a revised definition for major allergens based on effector function.

Main Methods:

  • In vitro assays measuring allergen-mediated cross-linking of IgE/FcεRI complexes.
  • Purification of allergens under non-denaturing conditions.
  • Chromatography and immunodepletion to remove specific allergens from extracts.
  • Murine models of peanut allergy to assess anaphylaxis and desensitization.

Main Results:

  • Potent allergens are not necessarily those with the highest IgE binding.
  • Peanut allergens Ara h 2 and Ara h 6 account for the majority of allergic effector activity.
  • Ara h 2 and Ara h 6 are major elicitors of anaphylaxis and can desensitize allergic mice.

Conclusions:

  • The definition of a major allergen should incorporate allergic effector activity.
  • Removal of Ara h 2 and Ara h 6 from peanut extract significantly reduces its potency.
  • Ara h 2 and Ara h 6 are identified as the major peanut allergens based on effector activity.